Clinical Trial Update: ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

This clinical trial update reports the results of the ToGA Phase 3 study comparing trastuzumab plus chemotherapy versus chemotherapy alone in patients with HER2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-11-05